| AMR | Antimicrobial resistance |
| AMC | Amoxicillin-clavulanic acid |
| AMK | Amikacin |
| AMP | Ampicillin |
| BSI | Bloodstream infections |
| CIP | Ciprofloxacin |
| CRE | Carbapenem-resistant Enterobacterales |
| CRAB | Carbapenem-resistant A. baumannii |
| CTX | Cefotaxime |
| CAZ | Ceftazidime |
| ERT | Ertapenem |
| DALYs | Disability-Adjusted Life Years |
| ESKAPE | E. cloacae, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, E. faecium |
| FOX | Cefoxitin |
| GEN | Gentamicin |
| GHC | Gentamicin high-charged |
| GLASS | Global Antimicrobial Resistance and Use Surveillance System |
| ICU | Intensive care unit |
| IMP | Imipenem |
| LART | L’Antibiorésistance en Tunisie |
| LIN | Linezolid |
| LIS | Laboratory information system |
| MDR | Multidrug resistant |
| MENA | Middle East and North Africa |
| MRSA | Methicillin-resistant S. aureus |
| OFL | Ofloxacin |
| PTZ | Piperacillin–tazobactam |
| TIG | Tigecycline |
| 3GC | Third-generation cephalosporin |
| 3GCREB | Third-generation cephalosporin-resistant Enterobacterales |
| VAN | Vancomycin |
| VRE | Vancomycin-resistant Enterococci |
| WHO | World Health Organization |